高级检索
当前位置: 首页 > 详情页

Glycyrrhizin surface-modified chitosan nanoparticles for hepatocyte-targeted delivery

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1] China Pharmaceut Univ, Fac Pharm, Dept Pharmaceut Technol, Nanjing 210009, Jiangsu, Peoples R China [2] Guangzhou Univ Tradit Chinese Med, Fac Clin Med 2, Guangzhou 510120, Guangdong, Peoples R China
出处:
ISSN:

摘要:
The aim of the present work was to investigate the potential utility of chitosan nanoparticles surface modified with glycyrrhizin (CS-NPs-GL) as new hepatocyte-targeted delivery vehicles. For this purpose, chitosan nanoparticles (CS-NPs) were prepared previously by ionic gelation process and glycyrrhizin was oxidized by sodium periodate to be conjugated to the surface of CS-NPs. The CS-NPs-GL obtained were first characterized for their morphology, particle size, zeta potential, association efficiency and in vitro release of adriamycin (ADR), using as a model drug. The nanoparticles were also labeled with rhodamine B isothiocyanate and their interaction with rat hepatocytes was examined by flow cytometry (FCM) and confocal laser microscopy (CLSM). The spherical nanoparticles prepared with oxidized GL/CS ratio of 0.14:1 (w/w) were in the 147.2 nm size range, and exhibited a positive electrical charge (+9.3 mV), and associated ADR quite efficiently (association efficiency: 91.7%) and showed lower extent of release (28% over 72 h) in vitro. FCM and CLSM studies showed that CS-NPs-GL were preferentially accumulated in hepatocytes and the cellular uptake amount were 4.9 times more than that in hepatic nonparenchymal cells, and the uptake process was dependent on incubation time and dose of nanoparticles, which indicated that the internalization of these nanoparticles into hepatocytes was mostly mediated by a ligand-receptor interaction. In conclusion, CS-NPs-GL as a promising hepatocyte-targeted delivery carrier holds promise for further effective studies. (C) 2008 Elsevier B.V. All rights reserved.

语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2007]版:
大类 | 3 区 医学
最新[2025]版:
大类 | 2 区 医学
小类 | 2 区 药学
JCR分区:
出版当年[2006]版:
Q2 PHARMACOLOGY & PHARMACY
最新[2023]版:
Q1 PHARMACOLOGY & PHARMACY

影响因子: 最新[2023版] 最新五年平均 出版当年[2006版] 出版当年五年平均 出版前一年[2005版] 出版后一年[2007版]

第一作者:
第一作者机构: [1] China Pharmaceut Univ, Fac Pharm, Dept Pharmaceut Technol, Nanjing 210009, Jiangsu, Peoples R China [*1]China Pharmaceut Univ, Fac Pharm, Dept Pharmaceut Technol, Nanjing 210009, Jiangsu, Peoples R China
通讯作者:
通讯机构: [1] China Pharmaceut Univ, Fac Pharm, Dept Pharmaceut Technol, Nanjing 210009, Jiangsu, Peoples R China [*1]China Pharmaceut Univ, Fac Pharm, Dept Pharmaceut Technol, Nanjing 210009, Jiangsu, Peoples R China
推荐引用方式(GB/T 7714):

资源点击量:2022 今日访问量:0 总访问量:648 更新日期:2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持:重庆聚合科技有限公司 地址:广州市越秀区大德路111号